Theme: Global Voices: Safer Medicines📅 June 20–21, 2026 | 📍 India (Virtual & In-person participation possible)🌍 Presented by the Global Pharmacovigilance Society
Are you advancing the science of drug safety, regulatory excellence, patient protection, or innovation in pharmacovigilance? This is your chance to share your research with a global audience!
🔬 We invite researchers, practitioners, academicians, and industry experts to submit original abstracts for presentation at the 4th Global Pharmacovigilance Congress 2026.
đź“„ Submission Guidelines
Abstracts should present original work in pharmacovigilance or related fields and must follow these requirements:
âś… Word Limit: Up to 250 words
âś… Format: IMRAD (Introduction, Methods, Results, Discussion)
âś… Mandatory Inclusions:
- Title of the abstract
- Full list of author names & affiliations
- Corresponding author details (name, email, contact number, ORCID ID)
âś… References: Optional, in APA style if included
âś… Graphical Abstract: Optional but encouraged
✍️ All submissions will be peer-reviewed by the scientific jury. Accepted abstracts will be published in the Abstract Book, and select high-impact works may be featured in the JPADR Journal.
🏆 Why Submit?
- Present your research to an international audience of regulators, practitioners, and thought leaders
- Contribute to global discussions shaping the future of patient safety & pharmacovigilance
- Top 20 best research papers will receive special awards 🎖️
đź“… Important Date
🗓️ Abstract Submission Deadline: April 30, 2026
🎯 Ready to submit? Prepare your abstract in line with the guidelines and be part of a congress that unites global expertise to protect patients and promote safer medicines worldwide.
If you’d like, I can also help you write a short social media version or a LinkedIn caption for this call!

Leave a Reply